BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37161649)

  • 1. BACH1 encourages ferroptosis by activating KDM4C-mediated COX2 demethylation after cerebral ischemia-reperfusion injury.
    Zhang T; Yang M; Ma C; Wei X; Zhang Z
    Eur J Neurosci; 2023 Jul; 58(1):2194-2214. PubMed ID: 37161649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POU Domain Class 2 Transcription Factor 2 Inhibits Ferroptosis in Cerebral Ischemia Reperfusion Injury by Activating Sestrin2.
    Yang J; Guo Q; Wang L; Yu S
    Neurochem Res; 2023 Feb; 48(2):658-670. PubMed ID: 36306010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rd enhances blood-brain barrier integrity after cerebral ischemia/reperfusion by alleviating endothelial cells ferroptosis via activation of NRG1/ErbB4-mediated PI3K/Akt/mTOR signaling pathway.
    Hu S; Fei Y; Jin C; Yao J; Ding H; Wang J; Liu C
    Neuropharmacology; 2024 Jun; 251():109929. PubMed ID: 38521230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis.
    Wang F; Ma M; Yang J; Shi X; Wang J; Xu Z
    ACS Chem Neurosci; 2023 Aug; 14(15):2818-2826. PubMed ID: 37473431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis.
    Wang Z; Li Y; Ye Y; Zhu H; Zhang J; Wang H; Lei J; Gu L; Zhan L
    Brain Res Bull; 2023 Feb; 193():37-46. PubMed ID: 36435361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-211-5p alleviates focal cerebral ischemia-reperfusion injury in rats by down-regulating the expression of COX2.
    Peng Z; Li M; Tan X; Xiang P; Wang H; Luo Y; Yang Y; Huang H; Chen Z; Xia H; Li Y; Zhang J; Gu C; Liu M; Wang Q; Chen M; Yang J
    Biochem Pharmacol; 2020 Jul; 177():113983. PubMed ID: 32311346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of ELAVL1 attenuates ferroptosis-induced neuronal impairment in rats with cerebral ischemia/reperfusion via reducing DNMT3B-dependent PINK1 methylation.
    Du Y; Zhang R; Zhang G; Wu H; Zhan S; Bu N
    Metab Brain Dis; 2022 Dec; 37(8):2763-2775. PubMed ID: 36173508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of BACH1 Protects AGAINST Cerebral Ischemia/Reperfusion Injury through the Functions of HO-1 and NQO1.
    Yu S; Zhai J; Yu J; Yang Q; Yang J
    Neuroscience; 2020 Jun; 436():154-166. PubMed ID: 32311410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PUM2 aggravates the neuroinflammation and brain damage induced by ischemia-reperfusion through the SLC7A11-dependent inhibition of ferroptosis via suppressing the SIRT1.
    Liu Q; Liu Y; Li Y; Hong Z; Li S; Liu C
    Mol Cell Biochem; 2023 Mar; 478(3):609-620. PubMed ID: 35997855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RXRγ attenuates cerebral ischemia-reperfusion induced ferroptosis in neurons in mice through transcriptionally promoting the expression of GPX4.
    Yang L; Du B; Zhang S; Wang M
    Metab Brain Dis; 2022 Jun; 37(5):1351-1363. PubMed ID: 35486208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chrysin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis in rats].
    Shang JF; Jiao JK; Li QN; Lu YH; Wang JY; Yan MX; Wen YL; Huang GJ; Zhang XL; Liu X
    Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(6):1597-1605. PubMed ID: 37005848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone Ameliorates Cerebral Ischemia-Reperfusion Injury by Downregulating Ferroptosis via the Nrf2/FPN Pathway in Rats.
    Liu W; Wang L; Liu C; Dai Z; Li T; Tang B
    Biol Pharm Bull; 2022; 45(9):1269-1275. PubMed ID: 36047195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
    Wang L; Liu C; Wang L; Tang B
    Eur J Pharmacol; 2023 Apr; 944():175516. PubMed ID: 36758783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aging Factor GRSF1 Attenuates Cerebral Ischemia-Reperfusion Injury in Mice by Inhibiting GPX4-Mediated Ferroptosis.
    Li Y; Shen Q; Huang L; Li B; Zhang Y; Wang W; Zhao B; Gao W
    Mol Neurobiol; 2024 Apr; 61(4):2151-2164. PubMed ID: 37861894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvia miltiorrhiza Bge. processed with porcine cardiac blood inhibited GLRX5-mediated ferroptosis alleviating cerebral ischemia-reperfusion injury.
    Zhou S; Wang Z; Wang T; Peng C; Zhang J; Liu C; Xu J; Zhang Y; Zhang L; Luo L; Yan X
    Phytomedicine; 2024 Jul; 129():155622. PubMed ID: 38677272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice.
    Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y
    Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxibustion ameliorates cerebral ischemia-reperfusion injury by regulating ferroptosis in rats.
    Zhang J; Cai W; Wei X; Shi Y; Zhang K; Hu C; Wan J; Luo K; Shen W
    Clin Exp Pharmacol Physiol; 2023 Oct; 50(10):779-788. PubMed ID: 37417429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis model system by the re-expression of BACH1.
    Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
    J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis.
    Zhao J; Wu Y; Liang S; Piao X
    Neuroscience; 2022 Mar; 485():78-90. PubMed ID: 35090880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis.
    Xie J; Zhang T; Li P; Wang D; Liu T; Xu S
    Drug Des Devel Ther; 2022; 16():3071-3085. PubMed ID: 36118165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.